Mesoporous silica formulation strategies for drug dissolution enhancement: a reviewCarol A. McCarthy, Abina M. Crean, Katie B. Ryan et al.|Expert Opinion on Drug Delivery|2015Cited by 190
Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug deliveryRobert J. Ahern, Abina M. Crean, John P. Hanrahan et al.|European Journal of Pharmaceutical Sciences|2013Cited by 117
The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical propertiesRobert J. Ahern, Katie B. Ryan, Abina M. Crean|International Journal of Pharmaceutics|2012Cited by 34
In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulationCarol A. McCarthy, Abina M. Crean, Waleed Faisal et al.|Journal of Controlled Release|2017Cited by 31
Porous Silicas for Enhanced Drug ReleaseAbina M. Crean, Katie B. Ryan, Brendan T. Griffin et al.|Advances in science and technology|2014Cited by 0